Xylem (XYL) EBT (2010 - 2026)

Xylem's EBT history runs 17 years deep, the most recent figure standing at $244.0 million for Q1 2026.

• On a quarterly basis, EBT rose 12.44% year-over-year to $244.0 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 9.03% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 8.65% from the prior year.
• EBT fell to $244.0 million in Q1 2026 per XYL's latest filing, from $368.0 million in the prior quarter.
• Across five years, EBT topped out at $375.0 million in Q4 2024 and bottomed at $17.0 million in Q3 2022.
• The 5-year median for EBT is $210.0 million (2023), against an average of $211.0 million.
• Across the five-year window, EBT slumped 87.22% in 2022 and jumped 988.24% in 2023, its largest moves.
• Year by year, EBT stood at $189.0 million in 2022, then gained by 11.11% to $210.0 million in 2023, then jumped by 78.57% to $375.0 million in 2024, then slipped by 1.87% to $368.0 million in 2025, then plunged by 33.7% to $244.0 million in 2026.
• Per Business Quant, the three latest XYL EBT figures stand at $244.0 million (Q1 2026), $368.0 million (Q4 2025), and $297.0 million (Q3 2025).